<DOC>
	<DOCNO>NCT01251835</DOCNO>
	<brief_summary>This study assess rifampin affect blood level sitaxsentan . Safety sitaxsentan give alone rifampin also assess .</brief_summary>
	<brief_title>Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Sitaxsentan</mesh_term>
	<criteria>Healthy male subject and/or woman nonchild bear potential . Subjects age 21 55 year , inclusive . Signed informed consent . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . Has hepatic dysfunction . Has history excessive alcohol tobacco use .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Sitaxsentan</keyword>
	<keyword>Rifampin</keyword>
	<keyword>Drug Interaction</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>